Events
Women’s HealthX welcomes top clinicians driving change across key health areas
Women’s HealthX has confirmed a new wave of clinical leaders, bringing together the decision makers shaping how therapies and technologies are adopted in real world care.
The event spans seven dedicated stages covering the full lifecycle of women’s health, from fertility and sexual health to maternity and menopause, giving attendees actionable insights from frontline leaders across hospitals and healthcare systems.
Confirmed sessions and trailblazers include:
Menopause & Healthy Aging
- The Heart of the Transition: Menopause and Cardiovascular Disease
Emily Lau, Co-Director, Women’s Heart Health Program, Brigham and Women’s Hospital
- Bridge the gaps in menopause education to advance awareness
Jan Shifren, Director, Massachusetts General Hospital Midlife Women’s Health Center
- Designing and scaling Menopause care practices – creating a safe space that supports the needs of all patients
Barb DePree, Director of Women’s Health, Holland Hospital
Sexual Health
- Provide improved sexual health care by understanding patient and clinician barriers
Suneela Vegunta, Vice Chair, Women’s Health Research Division, Mayo Clinic
Maternity & Maternal Care
- Partners in care: Bridge existing healthcare gaps caused by fragmentation between OB/GYN and birth workers
Christina Pardo, Medical Director, Women’s Health Practice, NewYork-Presbyterian Hospital
Fertility & Reproductive
- Prolong fertility preservation by highlighting ovarian insufficiency through genetic variant data analysis
Julie Rios, Division Director, Reproductive Endocrinology & Infertility, UPMC
Additional trailblazers joining the conversation include:
- Payal Srinivasa, Director of Reproductive Health/OBGYN, Fenway Health
- Gayatri Setia, Director of Preventive Cardiology, NYCHHC
- Catherine Monk, Founding Director, Center for the Transition to Parenthood
- Amanda Borsky, Director, Clinical Research, Northwell Health
Together, these speakers represent leading hospitals and healthcare systems, offering frontline insight into evolving care models and what it takes to implement change at scale.
View the full speaker list to see who else is joining the conversation.
The programme moves beyond discussion into delivery, giving attendees access to the latest clinical evidence, emerging digital tools, and real world outcomes data to support integrated, high quality care across the women’s health lifecycle.
With Chief Medical Officers and senior clinical leaders in attendance, Women’s HealthX brings together those turning innovation into practice.
For leaders shaping clinical strategy, building care pathways, or implementing new models, this is where adoption accelerates.
The women’s health sector is no longer just building a case for itself.
Capital is moving, consolidation is accelerating, and the companies that understood the opportunity early are now focused on one thing: scale.
The conversations happening at Women’s Health Week USA on May 13-14 at the New York Academy of Medicine reflect exactly that shift.
Three sessions in particular cut to the heart of where the industry is right now, and where it’s going next. Here’s a closer look at what’s on the full programme.
Key Panel Discussions
Who’s Backing the Boom: Inside the Capital Surge in Women’s Health
Capital is flowing into women’s health at record levels.
The question is no longer whether the sector will attract institutional investment, but where that capital is coming from, who it’s going to, and what it takes to unlock the next wave of commercial growth.
This session puts those questions to a panel with direct experience of deploying and raising capital in the sector.
Nicole Mooljee Damani (EY-Parthenon) moderates a conversation between Tara Bishop (Black Opal Ventures), Trish Costello (Portfolia), and Ramiz Khan (Wellcome Leap), three investors with distinct mandates and a shared focus on what actually moves the needle.
For founders and operators in the room, this session is a direct window into how the people writing the cheques are thinking.
What they’re backing, what they’re passing on, and what the current capital environment means for the companies building in women’s health right now.
Mergers & Acquisitions: Who’s Buying, Who’s Building, and Why
The M&A landscape in women’s health is heating up. Strategic acquisitions, consolidation plays, and corporate partnerships are reshaping the competitive map, and the decisions being made now will define the structure of the industry for years to come.
This panel examines the logic behind who’s acquiring and who’s holding, from the perspective of people operating at the sharp end of those decisions.
Oriana Papin-Zoghbi (AOA Dx), Monica Cepak (Wisp), Gabrielle de Briey (Hologic), and Johanna Grossman (New York Stock Exchange) bring a combined view that spans diagnostics, digital health, medtech and the capital markets infrastructure that underpins it all.
For anyone building a company with an eye on strategic exits, partnerships or acquisitions, this is the session that maps the terrain.
The Economics of Equity: How Inclusion Equals Growth Strategy
Inclusion isn’t a tickbox. It’s a growth lever. And the data increasingly backs that up.
This session makes the commercial case for equity in women’s health, examining how addressing underserved populations and closing health disparities doesn’t just serve social goals, it creates the biggest commercial opportunities in the sector.
The shift from impact metric to market strategy is already underway. This panel is where that argument gets made in full.
Annie Theriault (Cross Border Impact Ventures) moderates a conversation between Sharon Meers (Midi Health), Lauren Makler (Cofertility), Tanvi Patel (Amazon Pharmacy), and Julia Berenson (World Health Organisation). The breadth of that panel, spanning venture, fertility, pharma and global health policy, is itself a signal of how far the conversation has moved.
These three sessions are part of a broader two-day programme bringing together 700+ senior decision makers across investment, innovation, policy and medtech.
The event is built around curated 1:1 matchmaking, with introductions structured around each attendee’s commercial priorities.
Early Bird Pricing for Women’s Health Week USA is ending Friday April 17, to save up to $600 on your ticket to the Global Stage for Scale, book now!
Secure your place at Women’s Health Week USA
The women’s health sector is no longer just building a case for itself.
Capital is moving, consolidation is accelerating, and the companies that understood the opportunity early are now focused on one thing: scale.
The conversations happening at Women’s Health Week USA on May 13-14 at the New York Academy of Medicine reflect exactly that shift.
Three sessions in particular cut to the heart of where the industry is right now, and where it’s going next. Here’s a closer look at what’s on the full programme.
Key Panel Discussions
Who’s Backing the Boom: Inside the Capital Surge in Women’s Health
Capital is flowing into women’s health at record levels.
The question is no longer whether the sector will attract institutional investment, but where that capital is coming from, who it’s going to, and what it takes to unlock the next wave of commercial growth.
This session puts those questions to a panel with direct experience of deploying and raising capital in the sector.
Nicole Mooljee Damani (EY-Parthenon) moderates a conversation between Tara Bishop (Black Opal Ventures), Trish Costello (Portfolia), and Ramiz Khan (Wellcome Leap), three investors with distinct mandates and a shared focus on what actually moves the needle.
For founders and operators in the room, this session is a direct window into how the people writing the cheques are thinking.
What they’re backing, what they’re passing on, and what the current capital environment means for the companies building in women’s health right now.
Mergers & Acquisitions: Who’s Buying, Who’s Building, and Why
The M&A landscape in women’s health is heating up. Strategic acquisitions, consolidation plays, and corporate partnerships are reshaping the competitive map, and the decisions being made now will define the structure of the industry for years to come.
This panel examines the logic behind who’s acquiring and who’s holding, from the perspective of people operating at the sharp end of those decisions.
Oriana Papin-Zoghbi (AOA Dx), Monica Cepak (Wisp), Gabrielle de Briey (Hologic), and Johanna Grossman (New York Stock Exchange) bring a combined view that spans diagnostics, digital health, medtech and the capital markets infrastructure that underpins it all.
For anyone building a company with an eye on strategic exits, partnerships or acquisitions, this is the session that maps the terrain.
The Economics of Equity: How Inclusion Equals Growth Strategy
Inclusion isn’t a tickbox. It’s a growth lever. And the data increasingly backs that up.
This session makes the commercial case for equity in women’s health, examining how addressing underserved populations and closing health disparities doesn’t just serve social goals, it creates the biggest commercial opportunities in the sector.
The shift from impact metric to market strategy is already underway. This panel is where that argument gets made in full.
Annie Theriault (Cross Border Impact Ventures) moderates a conversation between Sharon Meers (Midi Health), Lauren Makler (Cofertility), Tanvi Patel (Amazon Pharmacy), and Julia Berenson (World Health Organisation). The breadth of that panel, spanning venture, fertility, pharma and global health policy, is itself a signal of how far the conversation has moved.
These three sessions are part of a broader two-day programme bringing together 700+ senior decision makers across investment, innovation, policy and medtech.
The event is built around curated 1:1 matchmaking, with introductions structured around each attendee’s commercial priorities.
Early Bird Pricing for Women’s Health Week USA is ending Friday April 17, to save up to $600 on your ticket to the Global Stage for Scale, book now!
Secure your place at Women’s Health Week USA
To mark Endometriosis Awareness Month, Women’s HealthX is excited to announce that Padma Lakshmi will join the event as a keynote speaker, bringing one of the most influential voices in women’s health advocacy to the stage.
Boston, March 30 2026 – New York Times bestselling author and Emmy nominated host and executive producer of Hulu’s Taste the Nation, Padma Lakshmi, is widely recognized for her impact across media, culture, and advocacy.
Named one of Time Magazine’s 100 Most Influential People in 2023, she has become a leading voice in women’s health through her advocacy on endometriosis.
Having spoken openly about her own experience with the condition, Lakshmi has helped raise awareness of delayed diagnosis, chronic pain, and systemic gaps in care.
As co-founder of the Endometriosis Foundation of America, she has played a key role in advancing education, research, and policy attention for a disease that affects millions globally.
At Women’s HealthX, Lakshmi will headline a fireside chat titled The Invisible Disease: What Endometriosis Reveals About the Future of Women’s Health. Endometriosis remains widely misunderstood, underfunded, and frequently diagnosed years too late.
Using the condition as a case study, the session will explore broader systemic challenges across women’s health, from research inequities to clinical blind spots.
The discussion will focus on how to create a clearer roadmap for policymakers, payers, and innovators committed to accelerating earlier diagnosis, improving treatment options, and driving more equitable investment in women’s health.
Attendees will gain insight into how addressing endometriosis can unlock wider progress across the healthcare system.
Through her advocacy and public voice, Lakshmi continues to challenge stigma, amplify underrepresented experiences, and call for a healthcare system where women’s pain is recognised and addressed.
At Women’s HealthX, audiences will hear firsthand what endometriosis reveals about the future of women’s health from one of its most influential and fearless advocates.
Find out more about her session at Women’s HealthX.
As the leading global event in women’s health, the exhibition unites stakeholders across the full lifecycle of care, bringing together over 750 leaders from pharma, biotech, healthcare systems, insurers, and government, all focused on implementing solutions that close the sex difference data gap and improve outcomes for women worldwide.
Attendance is free for any medical officers and leaders within hospitals and healthcare systems, pharma, biotech, corporate enterprises and government officials.
More about Lakshmi:
Alongside being the cofounder of Endometriosis Foundation of America, Lakshmi is also the creator and host and executive producer of America’s Culinary Cup, a new culinary competition show premiering on CBS in spring 2026 following the 50th season premiere of Survivor.
She is the creator of the critically acclaimed and Emmy nominated Hulu series Taste the Nation, which won the James Beard Foundation Award top prize in Visual Media Long Form, and previously served as host and executive producer of Bravo’s two time Emmy winning series Top Chef for 19 seasons, earning five Emmy nominations for Outstanding Host for a Reality Competition Program.
Beyond television, she serves as an American Civil Liberties Union Artist Ambassador for immigrants’ rights and women’s rights and as a Goodwill Ambassador for the United Nations Development Program.
She is also a visiting scholar at the Massachusetts Institute of Technology.
Lakshmi is the author of several books, including Easy Exotic, Tangy, Tart, Hot & Sweet, and her New York Times bestselling memoir Love, Loss and What We Ate. Her other works include The Encyclopedia of Spices & Herbs, the children’s book Tomatoes for Neela, and Padma’s All American: Tales, Travels and Recipes from Taste the Nation and Beyond, launching in November 2025.
The clock is running down.
Companies looking to compete in the Women’s Health Week USA Pitch Sessions have until April 10 to apply, with the sessions taking place on the mainstage at the New York Academy of Medicine on May 13-14.
This is not a side room competition.
The Pitch Sessions are staged in front of the full Women’s Health Week USA audience: 700+ senior decision makers spanning investors, corporates, payers, providers and policymakers, all convened around a single agenda: the commercial growth of women’s health.
Two categories. One stage.
Applications are open across two categories:
- Medical Devices & Therapeutics – for companies developing hardware, diagnostics, and treatment innovations in women’s health
- Consumer & Tech – for digital health, platforms, and consumer-facing solutions targeting women’s health outcomes
The format is deliberately designed to maximise visibility.
Pitching companies gain direct exposure to a room that includes some of the most commercially active organisations in the sector, and the introductions made during event week extend well beyond the stage itself.
Previous winners have gone on to raise funding and secure commercial partnerships, with Women’s Health Week USA providing a platform that accelerates both credibility and reach.
Applications are completely free. If selected, you must be registered to present.
Applications close April 10. Apply now to get in front of those finding their deal flow.
International Women's Day 20264 weeks agoWomen’s health innovation needs infrastructure, not just investment
Diagnosis4 weeks agoHome urine tests could detect breast cancer, endometriosis and PCOS
Diagnosis4 weeks agoBlood test shows promise in endometriosis
Hormonal health4 weeks agoWomen’s health leaders warn of censorship
Menopause4 weeks agoStudy reveals hidden menopause tech privacy concerns
Insight4 weeks agoBlood test predicts dementia 25 years before symptoms begin
News3 weeks agoFemtech World Awards announces deadline extension
News3 weeks agoLuna and Kindbody partner to bring data-driven insight to women’s health and fertility care